The average one-year price target for Werewolf Therapeutics (NasdaqGS:HOWL) has been revised to $7.14 / share. This is an ...

Investors might want to bet on Werewolf Therapeutics, Inc. (HOWL), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...

If you’re a massive fan of werewolves like I am, then I’d guess 1981 is one of your favorite years in film history. There was something wolf-y in the air, as that year gave us a full moon’s worth of ...

Add Yahoo as a preferred source to see more of our stories on Google. Cinematically, werewolf movies have often been told as coming-of-age sagas that serve as allegories for life changes and rites of ...